Expedited regulatory product approval in the time of COVID-19. | Ocul Surf;26: 345-348, 2022 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Expedited regulatory product approval in the time of COVID-19.

Novack, Gary D.

Novack GD; Department of Ophthalmology & Visual Sciences, University of California, Davis, USA; PharmaLogic Development Inc., San Rafael, CA, USA. Electronic address: gary_novack@pharmalogic.com.

Ocul Surf ; 26: 345-348, 2022 Oct.

Article in English | MEDLINE | ID: covidwho-1867439

Subject(s)

COVID-19; Humans; United States/epidemiology; United States Food and Drug Administration; Drug Approval; Consumer Product Safety

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Ocul Surf Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Ocul Surf Year: 2022 Document Type: Article